Abstract 16315: Olaparib, a Clinically Used Poly(adp-ribose) Polymerase Inhibitor, Protects Against Oxidant-Induced Cardiac Myocyte Death in vitro and Improves Cardiac Contractility During Early Phase After Heart Transplantation in an in vivo Rat Model